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ABSTRACT
Cataract, the opacification of eye lens, is the leading cause of blindness worldwide. At present, the only remedy is surgical removal 
of the cataractous lens and substitution with a lens made of synthetic polymers. However, besides significant costs of operation and 
possible complications, an artificial lens just does not have the overall optical qualities of a normal one. Hence it remains a significant 
public health problem, and biochemical solutions or pharmacological interventions that will maintain the transparency of the lens 
are highly required. Naturally, there is a persistent demand for suitable biological models. The ocular lens would appear to be an 
ideal organ for maintaining culture conditions because of lacking blood vessels and nerves. The lens in vivo obtains its nutrients and 
eliminates waste products via diffusion with the surrounding fluids. Lens opacification observed in vivo can be mimicked in vitro 
by addition of the cataractogenic agent sodium selenite (Na2SeO3) to the culture medium. Moreover, since an overdose of sodium 
selenite induces also cataract in young rats, it became an extremely rapid and convenient model of nuclear cataract in vivo. The main 
focus of this review will be on selenium (Se) and its salt sodium selenite, their toxicological characteristics and safety data in relevance 
of modelling cataractogenesis, either under in vivo or in vitro conditions. The studies revealing the mechanisms of lens opacification 
induced by selenite are highlighted, the representatives from screening for potential anti-cataract agents are listed. 
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cortical cataracts is around 50% (Hammond et al., 2001). 
´Congenital cataracts´ are present at birth indicating 
pathological changes during embryonic development of 
the lens. Lens development is the result of a series of induc-
tive processes (Graw, 2003), and one of the most impor-
tant events is the interaction of the lens placode with the 
surface ectoderm. ‘Sugar cataracts’ were noticed a long 
time before thorough case observations and medical treat-
ment became available (Robman and Taylor, 2005). These 
types of cataract are regarded to be associated either with 
diabetes (diabetic cataract), based on biochemical animal 
investigations (Fan et al., 2009; Kumar et al., 2009) as well 
as clinical and epidemiological studies (Chikamoto et al., 
2009; Theodoropoulou et al., 2010) or galactosemia (Bosh, 
2006). Pre-senile development of galactosemic cataract 
is a consequence of a hereditary disease that results in a 
defect in, or absence of, galactose-metabolizing enzymes.
At present, the only remedy from cataract is surgical 
removal of the opaque lens and substitution with a clear 
one made of synthetic polymers. However, in the UK half 
of the patients put on waiting lists for operation will die 
before getting surgery (Minassian et al., 2000). In the 
United States, over 1.3 million cataract operations are 
performed annually at a cost of 3.5 billion dollars. In 
developing countries there is simply no sufficient number 
Introduction
Cataract, the opacification of the lens of the eye, is the 
leading cause of blindness worldwide – it accounts for 
approximately 42% of all blindness. Thus more than 17 
million people are blind because of cataract and world-
wide, 28 000 new cases are reported daily. Approximately 
25% of the population over 65 and about 50% over 80 have 
serious loss of vision because of cataract (Minassian et al., 
2000). There are an estimated 50 million blind people in 
the world, and cataracts (opacities of the lens in the eye) 
are responsible for half of these cases (Johnson and Foster, 
2004). In the USA, over 1.2 million cataract operations are 
performed per year; the costs are over 3.4 billion $ (West, 
2000). 
For ´age-related cataracts´ ,  i t  i s  t h o u g h t  ( b a s e d  
on twin studies) that the heritability for nuclear and 
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of surgeons to perform cataract operations. Besides sig-
nificant costs of operation and possible complications, an 
artificial lens just does not have the overall optical quali-
ties of a normal lens (Spector, 2000). This is the reason for 
highly required biochemical solutions or pharmacological 
intervention that will maintain the transparency of the 
lens; it is estimated that a delay in cataract formation of 
about 10 years would reduce the prevalence of visuality 
disabling cataract by about 45% (Kupfer, 1984). Such a 
delay would enhance the quality of life for much of the 
world’s older and diabetic population and substantially 
diminish both the economic burden due to disability and 
surgery related to cataract.
Hence it remains a significant public health problem, 
and there is a need for suitable biological models that 
would test potential anti-cataract agents. The ocular lens 
would appear to be an ideal organ for maintaining culture 
conditions because of lacking blood vessels and nerves. 
The lens in vivo obtains its nutrients and eliminates waste 
products via diffusion with the surrounding fluids. The 
lens opacification observed in vivo can be mimicked in 
vitro by the addition of different cataractogenic agents to 
the culture medium (Dickerson et al., 1995; Saxena et al., 
1996; Padival and Nagaraj, 2006; Olofsson et al., 2007). 
Since an overdose of sodium selenite induces cataract 
in young rats (Shearer et al., 1997), it became an extremely 
rapid and convenient model of nuclear cataract. Sodium-
selenite-induced opacification of lens is widely used for 
studying the effects of various stresses on the lens, mod-
elling various mechanisms of cataract formation and for 
screening potential anti-cataract agents (Kinoshita, 1974; 
Chandra et al., 1992; Spector et al., 1998; Zigler et al., 
2003; Gosh and Zigler, 2005; Son et al., 2007).
This review will firstly deal with principal anatomical 
and physiological singularities about eye lens with special 
emphasis on specific lens proteins – crystallins. Second, 
the article will mention different experimental approaches 
applied in cataractogenic research. Third, the main focus 
of this review will be on selenium (Se) and its salt sodium 
selenite (Na2SeO3), their toxicological characteristics and 
safety data in relevance of modelling cataractogenesis, 
either under in vivo or in vitro conditions. The studies 
revealing the mechanisms of lens opacification induced 
by selenite will be highlighted, the representatives from 
screening for potential anti-cataract agents will be listed. 
Lens development, anatomy and physiology
The ocular lens is biconvex, relatively pliable and nor-
mally transparent tissue held in suspension by ciliary 
zonules between the aqueous and the vitreous humors. Its 
anatomical structure and location coupled with its physi-
cal and biochemical characteristics are geared towards 
maintaining an effective transmission and convergence of 
the visible frequencies of the electromagnetic spectrum 
from the environmental objects to the retina, meant for 
image formation and visual perception. Lens function to 
converge is also dependent on its pliability and conse-
quent adjustments in its curvature. The lens also acts as 
an optical filter so that the access of ultraviolet (UV) light 
to the retina is greatly minimized (Varma, 1991). 
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Figure 1. Lens – a single layer of epithelial cells covers the anterior cross section. The elongated fi  ber cells are in direct contact with the epithelial 
layer in the anterior region, and they make contact with the capsule in the posterior region. In the lens bow region the cells diff  erentiate, elongate, 
lose their organelles and begin to form newly diff  erentiated fi  ber cells (Sharma and Santhoshkumar, 2009). 5
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The eye lens is an avascular tissue encapsulated in 
a collagenous basement membrane-like material com-
posed of a single layer of epithelial cells on the anterior 
subcapsular surface (Kuszak, 1990). The lens derives 
all of its nutrients and oxygen from the aqueous humor 
and vitreous body. At the equatorial zone the epithelial 
cells begin to differentiate, elongating to become fiber 
cells, during which time they lose the organelles and 
begin synthesizing large quantities of structural proteins 
called crystallins. This process continues throughout life, 
though at a slowing down pace, with the younger/newer 
fiber cells pushing the older fibers to the center (nuclear) 
region of the lens (Figure 1). 
Although the lens has a limited number of cells and 
cell types, its development is complex (Jaffe and Horwitz, 
1990; Lovicu and Robinson, 2004). Lens development 
begins with the invagination of lens placode toward the 
optic cup to become the lens pit. The invagination process 
continues, the pit closes and a lens vesicle is formed in 
humans by embryonic day 33. Following this, the dif-
ferentiating epithelial cells start filling the vesicle until 
the whole cavity is obliterated with fiber cells by the end 
of the seventh week. The ‘first- formed’ fiber cells that 
occupy the center of the lens become the embryonic 
nucleus (Kuszak, 1990; Lovicu and Robinson, 2004) Lens 
development is not complete without the removal of all 
potential light-scattering organelles from the fiber cells, 
which is accomplished in a programmed process that 
involves proteases (Bassnett, 2002; Bassnett, 2009). The 
embryonic spherical lens, measuring about 0.35 mm in 
diameter initially, quickly begins to grow to an elliptical 
organ of about 35 mg by birth. Studies of human lenses 
ranging in age from 6 months to 99 years show that the 
lens actually grows in two phases, an “asymptotic phase” 
during the prenatal and early childhood periods and 
a linear phase during the rest of the life span (Jaffe and 
Horwitz, 1990; Augusteyn, 2007). Although it was once 
thought that lenses of males are heavier than lenses of 
females, new data do not support this notion (Augusteyn, 
2007). The best estimate of human lens weight can be 
obtained by the expression: 
W=1.38Ab+149exp^[exp^(1.6−3Ac)], 
where W is lens weight in mg, Ab is postnatal age in years 
and Ac is the time since conception in years (Augusteyn, 
2007). Because the lens is composed of a range of fibers 
representing different ages, it is an attractive tissue for 
studying the effects of aging on protein structure and 
function (Bloemendal, 1981).
There is little protein turnover in the lens, the majority 
of proteins consisting of long-lived α-, β-, γ-crystallins. 
These proteins appear to be specific to the lens, although 
they contain regions of sequence and structural homo-
logy comparable to other proteins. Lipids, approximately 
1% of wet weight of the lens, are found mainly in cell 
membranes. The major (50–60% of all lipids of the lens) is 
cholesterol (Jacob et al., 1999; Girao et al., 1999; VanMarle 
and Vrensen, 2000). 
Factors implicated in cataract
There is a coincident dehydration of the proteins and 
the lens itself. Together with modification of the protein 
and other constituents, these changes result in less 
flexibility upon aging. As the lens ages, the proteins are 
photooxidatively damaged, aggregate, and accumulate in 
lens opacities. Dysfunction of the lens due to opacifica-
tion is called cataract. The term “age-related cataract“ 
is used to distinguish lens opacification associated with 
old age from opacification associated with other causes, 
such as congenital and metabolic disorders, e.g. diabetes 
or galactosemia (Jacques and Taylor, 1991; Taylor and 
Nowell, 1997).
Half-lives of many of the lens proteins are measured in 
decades. The sunlight and oxygen that the lens is exposed 
to are associated with extensive damage to the long-lived 
lens proteins and other constituents. With progressive 
damage, the altered proteins accumulate, aggregate, and 
precipitate in opacities, or cataracts. The young lens has 
substantial reserves of antioxidants (e.g. vitamins C and 
E, carotenoids and glutathione (GSH) and antioxidant 
enzymes (e.g. superoxide dismutase (SOD), catalase 
(CAT), and glutathione reductase/peroxidase (GSR/GPx)) 
that may prevent damage. Proteolytic enzymes, called 
proteases, may selectively remove obsolete proteins and 
provide a second level of defense. Compromises of func-
tion of the lens upon aging are associated with and may 
be causally related to depleted or diminished primary 
antioxidant reserves, antioxidant enzyme capabilities, 
and diminished secondary defenses such as proteases. 
Environmental stress such as smoking and excessive 
UV-light exposure, appear to provide an additional 
oxidative challenge associated with the depletion of 
antioxidants as well as with enhanced risk for cataract 
(Taylor and Nowell, 1997). Other risk factors for cataract 
formation include diabetes, galactosemia, electromag-
netic radiation, life-threatening diarrhea, renal failure and 
many drugs (Cerami and Crabbe, 1986). The most com-
mon drugs and related compounds implicated in cataract 
formation, in humans and in experimental animals, are 
given in Table 1. 
Table 1. Drugs and related compounds implicated in cataract forma-
tion (Cerami and Crabbe, 1986).
Cataract in experimental animals
cyanate, methylisocyanate, N-methyl-N-nitrosourea, bisulphan, dinitrophenol, 
3-aminotriazole, naphthalene, triparanol and other inhibitors of cholesterol 
synthesis, ecothiopate iodide (phospholine iodide) and other cholinesterase 
inhibitors, diquat, chloroquine, chlopromazine and phenotiazines, adrenaline 
and morphine, steroids, bleomycin
Cataract in humans
barbiturates, alcohol, dinitrophenol, triparanol and other inhibitors of choles-
terol synthesis, cholinesterase inhibitors, phenotiazines and major tranquilizers, 
diuretics, steroids6
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Crystallins and their role in 
maintaining tranparency
Crystallins are the major structural proteins in the lens 
accounting for up to 90% of total soluble protein. There 
are three distinct families of crystallins: α-, β- and 
γ-crystallins. Among these, the α- and β-crystallins exist 
as oligomers, whereas the γ-crystallin is a monomer. 
Their structure, stability and short-range interactions 
are thought to contribute to lens transparency. The 
human lens is also susceptible to age-related degenerative 
changes such as accumulation of insoluble proteins and 
oxidative damage and hence senile cataracts are the most 
common form of cataract (Harding, 1991; Ponce et al., 
2006; Takemoto and Sorensen, 2008).
α-Crystallin, a member of the small heat shock pro-
tein family, constitutes a major portion of the eye lens 
cytoplasm. It constitutes up to 50% of the total protein 
(Bloemendal et al., 2004). α-Crystallin monomer has a 
molecular weight of 20,000. In humans, the lenticular 
α-crystallin exists as a heterooligomer of the approximate 
molecular weight of 800,000 with two subunits, αA and 
αB occurring in a stoichiometry of 3:1 (de Jong et al., 
1998). αA-Crystallin appears to be largely lens-specific, 
whereas αB-crystallin is also expressed in other tissues 
such as heart, skeletal muscle, kidney, and brain. Increased 
levels of αB-crystallin have been observed in many neu-
rodegenerative disorders, tumors and diabetic conditions 
(Klemenz et al., 1991; Kumar et al., 2005a). Both of these 
proteins are known for their chaperone activity as evident 
from suppression of protein aggregation. They presum-
ably protect other lens proteins from the adverse effects 
of heat, chemicals, and UV irradiation. In addition to pro-
viding refractive properties to the eye lens, α-crystallins 
are instrumental in maintaining transparency of the lens 
with their chaperone-like activity (Harding, 1991; Bera 
et al., 2002; Horwitz, 2003; Surolia et al., 2008). Recently 
it has been reported that some low molecular weight 
peptides found in aged and cataractous lens bind and 
reduce the chaperone-like activity of α-crystallin (Rao et 
al., 2008).
The proteins of the eye lens are extremely long-lived 
and there is virtually no protein turnover. This provides 
great opportunities for post-translational modifications 
(PTMs) to occur, most of which lead to aggregation and this 
process is further accelerated due to various physiological, 
environmental and genetic factors that predispose lens to 
cataract formation (Harding, 1991). PTMs were found to 
induce changes of higher order structure of lens proteins 
related to opacification (Zhang et al., 2001; MacCoss et 
al., 2002; Fujii et al., 2004; Ponce et al., 2006; Wilmarth 
et al., 2006; Zhang et al., 2007; Takemoto and Sorensen, 
2008; Kanamoto et al., 2009; Hains and Truscott, 2010).
Multiple biochemical mechanisms are involved in the 
opacification of the lens and they have been thoroughly 
described: i) non-enzymatic glycation (Thorpe and 
Baynes, 1996; Lapolla et al., 2006; Padival and Nagaraj, 
2006), ii) oxidative stress (Spector, 2000; Paron et al., 
2004; Niwa, 2007), iii) polyol pathway (Jedzniak et al., 
1981; Kador et al., 2007; Lorenzi, 2007) and iv) activation 
of calpain proteases (Chandrasekher and Cenedella, 1993; 
Ma et al., 1999; Nakamura et al., 2000).
Diff  erent experimental approaches 
in cataractogenic research 
Especially in rodents the observation of eye lens proteome 
related changes have been studied preferentially on the 
aging model of cataract (Cenedella, 1998; Lampi et al., 
2002; Ueda et al., 2002; Descamps et al., 2005) or on the 
hereditary cataract model (Fujii et al., 2004). However, 
only few of the research articles were found to be related 
to diabetic cataractous state in particular (Satake et al., 
2003; Kumar et al., 2005a; Kumar et al., 2005b). 
Although dogs (Kador et al., 2007; Gift et al., 2009) and 
rabbits (Cheng, 2002; Babizhayev et al., 2009) might be 
commonly used, rodents still remain the most common 
experimental animals used to study the mechanisms of 
cataract formation. Several experimental treatments 
aimed at inducing cataracts in rats include streptozotocin-
induced diabetes (Kyselova et al., 2005a; Kyselova et al., 
2005b), galactose feeding (Huang et al., 1990; Huang et al., 
2000), ionizing radiation (Worgul et al., 1996), inhibition 
of cholesterol synthesis and steroid treatment (Dickerson 
et al., 1997), overdose of selenite (Shearer et al., 1997), 
and finally culture with oxidants or calcium ionophore 
(Chandrasekher and Cenedella, 1993; Fukiage et al., 1997; 
Nakamura et al., 1999; Mitton et al., 1999). 
 In most of these models, covalent modification of 
crystallins, followed by phase separation of lens cytosol 
and formation of water-insoluble aggregates, may play 
important roles in opacification. Some of the modifica-
tions detected in rat crystallins that could contribute to 
insolubilization are mixed disulfide formation (Lou et al., 
1995; Kyselova et al., 2005c), glycation (Swamy-Mruthinti 
et al., 1996), cross-linking by UV-light (Dillon et al., 1989), 
transglutaminase (Groenen et al., 1994) or disulfides 
(Ozaki et al., 1987), phosphorylation (Ito et al., 1999) and 
proteolysis (David et al., 1993). 
The ocular lens would appear to be an ideal organ for 
maintaining culture conditions because of lacking blood 
vessels and nerves. The lens in vivo obtains its nutrients 
and eliminates waste products via diffusion with the sur-
rounding fluids. 
Lens opacification observed in vivo can be mimicked 
in vitro by the addition of a cataractogenic agent to the 
culture medium – e.g. galactose (Saxena et al., 1996) 
or high glucose (Padival and Nagaraj, 2006; Dickerson 
et al., 1995; Olofsson et al., 2007; Son et al., 2007). 
Parenthetically, the lenses from various species have been 
incubated successfully since the middle of the last century 
(Kuck, 1970). Different research groups utilized rat lenses 
in organ culture as a model system for studying the effects 
of various stresses on the lens, mechanisms of cataract 
formation, and for screening potential anti-cataract 
agents (Kinoshita, 1974; Spector et al., 1998; Zigler et 
al., 2003; Ghosh and Zigler, 2005). In certain instances 7
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lens opacification induced in vivo by administration of 
a particular cataractogenic agent can be mimicked in 
vitro by addition of the same agent to the culture medium 
– e.g. naphthalene (Xu et al., 1992; Lee and Chung, 
1998), selenite (Biju et al., 2007a), transforming growth 
factor-β (Hales et al., 1995), methylglyoxal (Shamsi et 
al., 2000) or high glucose (Padival and Nagaraj, 2006; 
Dickerson et al., 1995; Olofsson et al., 2007; Son et al., 
2007; Devamanoharan and Varma, 1995). Further, agents 
which prevent such cataracts in vivo may also be effective 
in culture (Son et al., 2007; Zigler et al., 2003; Chandra 
et al., 2002). Thus, there is good evidence to support the 
idea that lenses in culture can be an effective model for 
the lens in vivo.
Two-faced biological function of selenium
Selenium (Se) is an essential trace element for humans, 
animals, and some bacteria. It is important for many 
cellular processes: it is dietarily essential, being specifi-
cally incorporated into the active sites of several known 
proteins or enzymes as the amino acid selenocysteine 
(Letavayova et al., 2006). It is pharmacologically active 
and at supranutritional dietary levels can prevent the 
development of many cancers, thus demonstrating che-
moprevention and/or carcinostatic activities (Rayman, 
2005). Moreoever, Se functions in the body as an antioxi-
dant, it is involved in thyroid hormone metabolism, redox 
reactions, reproduction, and immune function (Rayman, 
2000; Combs et al., 2009). Selenium has however been 
shown to induce wide-spread oxidative stress in biologi-
cal systems (Manikandan et al., 2009). Ironically, it forms 
an important part of biological defense, being the key 
component of selenoproteins, such as GPx, selenoprotein 
P and thioredoxin reductases (Stadtman, 1991). Indeed, 
Se has been shown to protect against cadmium-mediated 
apoptosis by regulating reactive oxygen species (ROS) 
generation and mitochondria linked signaling pathways 
(Zhou et al., 2009). 
Selenium has been linked to regulatory functions in 
cell growth, survival and cytotoxicity, as well as trans-
formations possibly involving redox regulation, chemical 
toxicity (Zhou et al., 2009). Some reports showed that 
Se can ameliorate the kidney damage induced by HgCl2 
injection (El-Shenawy and Hassan, 2008), and Se also had 
hepato-protective effects against cadmium toxicity in rats 
(Newairy et al., 2007). These reports showed that protec-
tion of Se treatment might be associated with recovering 
inhibition of GPx and thioredoxin reductase activities, 
decreasing free radical-mediated lipid peroxidation and 
GSH regeneration (Gan et al., 2002).
Selenium intake is mainly in the form of organic 
compounds ingested in grains, meat, yeast, and vegetables 
(Cao et al., 2004). The Food and Nutrition Board, USA 
Institute of Medicine (2000) considered the estimated 
safe and adequate daily intake for Se to be 50–200 μg, with 
55  μg/day being the Recommended Dietary Allowance 
(RDA) for Se for both men and women. The upper Se levels 
(the highest daily level of Se intake that is likely to pose 
no risk of adverse health effects in almost all individuals) 
were fixed at 400  μg Se/day. The No Observed Adverse 
Effect Level (NOAEL) of dietary Se was estimated to be 
1,540–1,600 μg/day (Whanger, 2004).
At higher dietary levels, many Se compounds can 
become toxic (Spallholz, 1994). All these attributes of Se 
mainly depend upon the concentration, the chemical form 
and metabolic activity of the compound (El-Bayoumy, 
2001; Whanger, 2004). A common specific characteristic 
of Se compounds expressing the carcinostatic activity 
and toxicity in vitro and in vivo is their interaction with 
thiols and the generation of free radical species (Kramer 
and Ames, 1988; Spallholz, 1997). In accordance with the 
prooxidant activities of Se, the higher doses of some Se 
compounds have the potential to induce DNA damage 
(Lu et al., 1994, 1995; Zhou et al., 2003; Reid et al., 2004; 
Wycherly et al., 2004; Waters et al., 2005).
Chronic exposure in humans or animals results in 
selenosis (Goldhaber, 2003). Selenosis is characterized by 
hair loss, fingernail changes and brittleness, gastrointes-
tinal disturbances, skin rash, garlic breath, and abnormal 
functioning of the nervous system. Other related toxic 
effects are disruption of endocrine function, of synthesis 
of thyroid hormones and growth hormones, and an 
insulin-like growth factor metabolism (Navarro-Alarcon 
and Cabrera-Vique, 2008). The mechanism of Se toxicity 
has not been clarified but mostly attributed to its ability to 
induce oxidative stress both in vitro and in vivo (Kitahara 
et al., 1993; Yan and Spallholz, 1993; Manikandan et al., 
2009; Valdiglesias et al., 2009)
Selenite model of cataractogenesis
The selenite cataract model is the most commonly used 
as it partially mimics senile nuclear cataract in humans. 
This chapter will briefly outline the methodological 
particulars and will try to explain possible mechanisms 
of cataract formation induced by sodium selenite. Since 
the model has been used by several investigators to screen 
a variety of agents having anti-cataract potential, their 
representatives will be outlined. 
Experimental approaches in vivo
S e l e ni t e - o v e r d o s e  c a t ar a c t  i s  an  e xt r e m e l y  r a p i d  an d  
convenient model of nuclear cataracts in rats in vivo. 
Sodium selenite is a cataractogenic agent commonly used 
in experimental studies since 1978 (Ostadalova et al., 
1978). Selenite cataract is usually produced by a single 
subcutaneous injection of 19–30  μM/kg body weight of 
sodium selenite (Na2SeO3) into suckling rats of 10–14 
days of age, definitely before the completion of the critical 
maturation period of the lens at approximately 16 days of 
age (Shearer et al., 1997). Repeated injections of smaller 
doses of selenite (Huang et al., 1992) or oral administra-
tion (Shearer et al., 1983) are also cataractogenic.
Severe, bilateral nuclear cataracts are produced within 
4–6 days. Precursor stages include: posterior subcapsular 8
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cataract (day 1), swollen fibers (day 2–3), and perinuclear 
refractile ring (day 3). Although the model has been used 
extensively as a model for nuclear cataract, a transient 
cortical cataract also forms 15–30 days after injection 
(Shearer et al., 1992). The cortical cataract then clears after 
several months, but the nuclear cataract is permanent. 
Similarly, Andreson et al. (1988) observed that after 
a single injection of an overdose of sodium selenite at 
30  μM/kg b.w., the nuclear cataract appeared rapidly 
within 3–5 days after injection and was permanent, while 
cortical cataract developed 15–30 days after injection 
and cleared within a few months. The selenite cortical 
cataract appeared to arise from early epithelial damage 
which interrupted normal fibergenesis and interfered 
with normal ion control, resulting in an influx of water, 
cellular destruction and opacity. Remarkably, selenite cor-
tical cataract spontaneously cleared after several months, 
restoring essentially normal cells to the epithelium and 
outer and mid-cortex. Major mechanisms for clearing 
probably involved: (1) removal of damaged proteins from 
the lens by extensive proteolysis; and (2) replacement of 
fibers by resumption of normal fibergenesis. Their data 
emphasized the remarkable reparative potential of the 
lens to restore clarity after severe damage.
Experimental approaches in vitro
Usually Wistar rats of either sex in the weight range of 100 
to 200 g can be used for the study. When these rats are 
killed the eyes are enucleated without delay. The lenses are 
carefully dissected out from a posterior approach to avoid 
damage. Next, according to Biju et al. (2007b), the lenses 
are cultured as organs in M-199 medium with HEPES 
buffer, supplemented with 10% fetal calf serum (FCS), 100 
U/ml penicillin, 0.1 mg/ml streptomycin, and 0.25 μg/ml 
amphotericin under 5% CO2 at 37 °C in a CO2 incubator. 
Selenite medium is prepared by adding sodium selenite 
to the medium to give a final concentration of 0.1 mM. 
Lenses are maintained in a 24-well culture plate with 2 
ml medium/well and one lens/well for five days. Lenses 
developing opacification in the first 24 h are discarded 
because of high suspicion for ruptures during prepara-
tion. Then, as early as twenty-four hours of incubation in 
the presence of sodium selenite lenses result in a dense 
cortical vacuolization and opacification. 
Sodium selenite safety concerns 
Sodium selenite is a salt, a colorless solid, and the most 
common water-soluble selenium compound. It has the 
formulas Na2SeO3 and Na2SeO3(H2O)5. Respectively, 
these are the anhydrous salt and its pentahydrate. The 
latter salt is the more common one.
The LD50 (intravenous) for sodium selenite in rats 
is listed in the Material Safety Data Sheet (Sigma) as 3 
mg/kg. The cataractogenic dose is 2.4 mg/kg (Shearer 
et al., 1997). This dose does not cause observable effects 
in suckling rats, except for occasional skin lesions at the 
injection site. Furthermore, sodium selenite is excreted 
in urine, feces, and expired air. Precautions are needed 
for animal handlers and for disposal of sodium selenite 
injection solutions, animal cadavers and wastes. A sig-
nificant portion of this dose is retained in the cadavers 
because Se is incorporated into tissue proteins (Shearer 
and Hadjimarkos, 1973).
Mechanism of cataract formation induced by sodium selenite
As indicated above, in both experimental approaches, 
either in vivo or in vitro, sodium selenite manifests its 
effect on lens by inducing primarily oxidative stress in lens 
tissue. However, its exact mode of action is still open to 
debate. Fris et al. (2006) hypothesized that the formation 
of selenite-induced nuclear cataract is a result of GSH loss 
from the lens. Thereafter, the capacity of GSH to buffer the 
oxidation⁄reduction status of lens metabolism is dimin-
ished, and the sensitivity of rat lenses to oxidative stress 
is enhanced. As a consequence of selenite treatment, the 
metabolic profile of the rat lens is dramatically changed. 
Between 24 and 96 hours after selenite injection, the total 
pool of free amino acids (excluding taurine) is elevated 
and remains increased for 8 days (Mitton et al., 1997). The 
water content in the lenses remains stable over this period, 
so that changes in concentrations of specific amino acids 
reflect firstly altered metabolism. Furthermore, the energy 
metabolism in the lens is impaired. Selenite reaction with 
GSH increases requirements for energy compounds like 
reduced nicotinamide adenine dinucleotide phosphate 
(Mitton et al., 1997) and the enhanced demand is met by 
activation of the pentose phosphate pathway in the lens 
(Kinoshita and Wachtl, 1958), resulting in accumulation 
of three-carbon metabolites.
The selenite-induced nuclear cataract formation is 
caused by various contributing mechanisms summarized 
in Figure 2, including calpain-induced hydrolysis and pre-
cipitation of lenticular proteins. Calpains (EC 3.4.22.17) 
are a family of non-lysosomal cysteine proteases with a 
neutral pH optimum and a requirement of calcium for 
activation.
Documented changes in the metabolism of lenticular 
epithelial cells during selenite cataractogenesis (usually 
well before the appearance of any visible opacity) include 
suppression of mitosis and entry of epithelial cells into 
prophase, nuclear fragmentation (Anderson et al., 1986), 
decreased rate of epithelial cell differentiation (Cenedella, 
1987), increased damage to DNA (Huang et al., 1990), and 
loss of calcium homeostasis (Wang et al., 1993). In fact, 
normal and selenite cataractous lenses have been found 
to differ in the expression of 91 different genes, with the 
most obvious differences being noted in the cytochrome 
c oxidase subunit I (COX-I) and gastric inhibitory poly-
peptide genes (expression of these genes was found to be 
decreased in selenite cataractous lenses) and in the early 
growth response protein-1 (EGR-1) gene (expression of 
this gene was found to be increased in selenite cataractous 
lenses; Nakajima et al., 2002). Interestingly, two of these 
three genes, namely EGR-1 and COX-I, are involved in 
apoptosis (Nakajima et al., 2002).  
The accelerated apoptosis (programmed cell death) 
can be regarded as an additional mechanism for selenite 
cataract. For example, apoptosis in lens epithelial cells 9
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could lead to loss of lens homeostasis, allowing calcium 
influx into the underlying fiber cells. Recently apoptosis 
i n  l e n s  e p i t h e l i u m  w a s  p r o p o s e d  a s  c o n t r i b u t i n g  t o  
calcimycin-induced cataract (Li et al., 1995a) and to the 
UVB-induced cataracts (Michael et al., 1998). During 
normal development of the eye, apoptosis is required 
for the separation of the lens from the future corneal 
epithelium (Garcia-Porrero et al., 1979; Schook, 1980) 
and for removal of the tunica vasculosa lentis and the 
anterior pupillary membrane (Lang et al., 1994; Latker 
and Kuwabara, 1981). Removal of cells is beneficial to the 
organism, but apoptosis may be triggered prematurely, 
as in neurons subjected to ischemic conditions resulting 
from heart attack or stroke (Vaux and Strasser, 1996; 
Hetts, 1998) or during retinal ganglion cell death in glau-
coma (Quigley et al., 1995). Calpain and other proteases, 
such as caspases, are involved in cell death in other tissues 
(Wang et al., 1996), and these enzymes might likewise be 
activated after the oxidative damage to the lens caused by 
selenite. The experimental data of Tamada et al. (2000) 
indicated that apoptosis was increased in selenite cataract 
and that m-calpain and caspase activity were activated, 
thus apoptosis may be a fairly early event in selenite cata-
ract. Moroeover, apoptosis in lens epithelial cells has been 
reported in other cataract models. Li et al. (1995b) dem-
onstrated that lens epithelial cells from human cataract 
patients exhibited much higher rates of apoptosis than 
age-matched controls. The lens is reliant on the epithelial 
layer of cells for maintaining metabolic homeostasis 
(Spector, 1991). In cultured rat lenses subjected to per-
oxide, lens epithelial apoptosis preceded cataract forma-
tion. Similar inducers of cataract formation, such as UV 
irradiation (Michael et al., 1998), are also known to induce 
apoptosis. It is possible that diverse types of cataracts may 
be initiated through a common mechanism involving 
apoptosis in the lens epithelium.
Of the all above-mentioned biochemical processes 
contributing to cataractogenesis, ionic homeostasis 
seems to be an integrating factor for maintenance of lens 
transparency (Biju et al., 2007b). Loss of Ca2+ homeostasis 
has been implicated in most types of cataract (Duncan 
et al., 1993; Duncan et al., 1 994 ) . Lev els of Ca 2+ are 
maintained in the sub-μM range in the cytoplasm by 
membrane Ca2+ pumps (Galvan and Louis, 1988), plasma 
membrane Na+/Ca2+ exchangers (Churchill and Louis, 
1999), and endoplasmic reticulum Ca2+ pumps (Shearer et 
al., 1997). Increased Ca2+ uptake performed in connection 
with selenite cataractogenesis, was found to be highest 
in the nucleus (Hamakubo et al., 1986). An important 
consequence of calcium elevation in lens is the activation 
of calpains (Shearer et al., 1997). Studies on experimental 
cataract have demonstrated calpain-induced proteolysis 
of β-crystallin as a major mechanism in lens maturation 
as well as cataractogenesis (David et al., 1994). Lp82 is the 
dominant isoform of calpain in rodent lens, suggesting 
that it may be responsible for the proteolysis attributed 
t o  c a l p a i n s  i n  e x p e r i m e n t a l  c a t a r a c t .  A l t e r a t i o n s  t o  
membrane proteins, lipid integrity, and the consequent 
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Figure 2. Mechanims of selenite-induced nuclear cataract formation (Shearer et al., 1997 - modifi  ed). 10
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increase of membrane ion permeability of the lens fiber 
cells have been reported in different pathological condi-
tions (Jacques and Chylack, 1991; Stitt, 2001). Thus, 
selenite-induced oxidative stress and the subsequent loss 
of Ca2+ homeostasis are responsible for the activation of 
lens calpains, which results in proteolytic precipitation 
and aggregation of soluble proteins to insoluble proteins.
Potential anti-cataract agents tested in the selenite model
Selenite-induced oxidative stress mediated cataracto-
genesis has been shown to be prevented by antioxidative 
agents such as caffeic acid phenethyl ester (Doganay et 
al., 2002), 2-ketoglutarate (Varma and Hedge, 2004) and 
extract of Ocimum sanctum (Gupta et al., 2005). In these 
studies, the putative anti-cataractogenic effect is thought 
to be due to the maintenance of normal antioxidant levels 
and preventing alterations of lens protein. Gupta et al. 
(2002) evaluated the anticataract potential of polypheno-
lic compounds present in green tea (Camellia sinensis). 
Their results suggest that green tea possesses significant 
anticataract potential and acts primarily by preserving 
the antioxidant defense system. Another nutritional anti-
oxidant, lycopene, was tested by Gupta et al. (2003) and 
again was shown to protect against experimental cataract 
development by virtue of its antioxidant properties. 
Resveratrol, a phytoalexin produced naturally by sev-
eral plants, was able to suppress selenite-induced oxida-
tive stress and cataract formation in rats (Doganay et al., 
2006). Its protective effect was supported by the finding 
of higher GSH and lower malondialdehyde (MDA) levels 
in lens and erythrocytes. 
Study of Yağci et al. (2006) with the rat selenite cata-
ract model strongly supported the activity of melatonin 
as an endogenous antioxidant and anticataract agent: in 
the melatonin-treated group, the lens and serum levels of 
the lipid peroxidation marker MDA and oxidative stress 
indicators as xanthine oxidase and protein carbonyls 
were significantly decreased. On the contrary, the levels 
of antioxidant enzymes SOD and CAT were significantly 
increased when compared with the selenite non-treated 
group.
The study of Biju et al. (2007b) was aimed to test 
Drevogenin D, a triterpenoid aglycone isolated from a 
woody climbing plant Dregea volubilis, as a potential 
therapeutic agent against oxidative stress-induced cata-
ract. The results obtained indicated that Drevogenin D 
treatment was effective in protecting the lens proteins 
by controlling stress-induced protein oxidation, main-
tenance of Ca2+ ATPase activity, calcium accumulation, 
lipid peroxidation, and prevention of calpain activation. 
Among potential anti-cataract agents, positive outcomes 
for good antioxidant activities were found for acetyl-L-
carnitine (Elanchezhian et al., 2007) and ellagic acid – a 
naturally-occurring polyphenol (Sakthivel et al., 2008).
In 2009, the rising number of studies using selenite 
models and screening for anti-cataract agents indicates 
the increasing interest of investigators for the given topic. 
A herbal remedy was recommended for treatment by 
Javadzadeh et al. (2009a): in their study intraperitoneal 
injection of aqueous garlic extract into rats appeared 
to effectively prevent selenite-induced cataract in vivo. 
Surprisingly for onion, a further work of Javadzadeh et 
al. (2009b) testing instillation of onion juice into the rat 
eyes (one drop of 50% diluted fresh juice of crude onion, 
applied every 8 hours into the right eye for 14 days) also 
showed effective prevention of selenite-induced cataract 
formation. This was associated with increased total anti-
oxidant level and the activities of SOD and GPx within the 
lens. The prevention of selenite-induced cataractogenesis 
was also declared by rutin (Isai et al., 2009a), by an extract 
of the oyster mushroom Pleurotus Ostreatus (Isai et al., 
2009b), by curcumin and aminoguanidin (Manikandan 
et al., 2009), by N-acetyl cysteine (Aydin et al., 2009) and 
finally by a topical use of coenzyme Q10-loaded liposomes 
coated with trimethyl chitosan (Zhang and Wang, 2009).
Tamada  et al. (2001) tested the calpain inhibitor 
SJA6017 which ameliorated in vivo selenite cataract for-
mation in rats, thus stressing the significance of calcium 
homeostasis for manitaining healthy lens conditions. 
Recently Rooban et al. (2009) tested phytochemical anti-
oxidants isolated from Vitex negundo. Using the selenite-
induced cataract model, they assessed the efficacy of 
flavonoids tested in preventing changes associated with 
oxidative stress, loss of calcium homeostasis, calpain acti-
vation and protein insolubilization in the lens. The activi-
ties of SOD, CAT, Ca2+ ATPase, concentration of reduced 
GSH and protein sulfhydryl content were significantly 
increased in treated groups compared to the non-treated 
one. Moreover, decreased activities of calpains, lower 
concentration of calcium and thiobarbituric acid reactive 
substances (TBARS) were observed in treated groups as 
compared to the non-treated one. 
The differential expression of apoptotic genes has been 
demonstrated in selenite-induced cataract (Nakajima et 
al., 2002). Recently, Elanchezhian et al. (2010) carried 
out an experiment to investigate the possibility of acetyl-
L-carnitine (ALCAR) to prevent selenite-induced cata-
ractogenesis by regulating the expression of antioxidant 
(CAT) and apoptotic (caspase-3, EGR-1 and COX-I) genes. 
The expression of lenticular caspase-3 and EGR-1 genes 
appeared to be up-regulated, as inferred by detecting 
increased mRNA transcript levels, while that of COX-I 
and CAT genes appeared to be down-regulated (lowered 
mRNA transcript levels) in the lenses of cataract-untreated 
rats. However, in rats treated with ALCAR, the lenticular 
mRNA transcript levels were maintained at near normal 
(control) levels. Their results suggest an original approach 
how to prevent selenite-induced cataractogenesis by 
affecting the abnormal expression of lenticular genes 
governing apoptosis.
Concluding remarks towards 
selenite model relevancy
Oxidative stress as a contributing mechanism is a key fac-
tor in modelling cataractogenesis. Most of the effects of 
anti-cataract compounds tested (see chapter above) were 11
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elucidated by their antioxidant actions. Thus, the model 
is relevant since selenite is a strong oxidant. Selenite-
induced opacification of lens may partially mimic oxidant 
exposures commonly present in the environment of a man 
(e.g. from sunlight) and/or occurring at pathophysiologi-
cal conditions (e.g. diabetes, aging etc.). 
According to Doganay et al. (2002) selenite cataract 
has many general similarities to human cataract, e.g. 
lipid membrane vesicles f orma tion, increased level of  
calcium, elevated amount of insoluble proteins, enhanced 
proteolysis, decreased amount of water soluble proteins 
and declined level of GSH. Major dissimilarities are also 
present contrary to human cataract: no high molecular 
weight covalent aggregates or increased disulfide forma-
tion. Selenite cataract appears to be dominated by rapid 
calpain-induced proteolytic precipitation (Shearer et al., 
1997), while human senile cataract may be caused by 
oxidative stress over a long period. Currently, the best 
conclusion about the relevancy of selenite cataract model 
to human cataract may be that selenite cataract is a useful  
biological model for initial drug testing. However, impor-
tant differences between human and selenite cataracts 
have to be taken into consideration when scaling up the 
verdicts. 
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